Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
PSORIASIS-TARGETS AND THERAPY
PSORIASIS-TARGETS AND THERAPY is indexed in Web of Science (ESCI), DOAJ. Published by DOVE MEDICAL PRESS LTD.
Checked against the index lists dated .
ISSN 2230-326XVerify ISSN ↗
Publisher: DOVE MEDICAL PRESS LTD
WoS · ESCIOpen Access
2
Indexed in
Cost to publish: Checking DOAJ for article charges…
DOAJDirectory of Open Access Journals (live)
Listed in DOAJ
Open accessFully open access, peer reviewed
Not listed in: Scopus, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is PSORIASIS-TARGETS AND THERAPY indexed in Scopus?
No — PSORIASIS-TARGETS AND THERAPY is not currently indexed in Scopus.
What is the impact factor of PSORIASIS-TARGETS AND THERAPY?
PSORIASIS-TARGETS AND THERAPY is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. Scopus has not published a current CiteScore for this title.
How much does it cost to publish in PSORIASIS-TARGETS AND THERAPY?
The publisher lists an article processing charge of about US$2,320 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes PSORIASIS-TARGETS AND THERAPY and what is its ISSN?
PSORIASIS-TARGETS AND THERAPY is published by DOVE MEDICAL PRESS LTD. Its ISSN is 2230-326X.
Is PSORIASIS-TARGETS AND THERAPY in Web of Science?
Yes — indexed in the Emerging Sources Citation Index.
Is PSORIASIS-TARGETS AND THERAPY open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is PSORIASIS-TARGETS AND THERAPY? — open metrics via OpenAlex
PSORIASIS-TARGETS AND THERAPY has an h-index of 34 and a 2-year mean of 2.74 citations per paper (OpenAlex).
34
h-index
2.74
2-yr mean citations
88
i10-index
231
works indexed
3,911
total citations
Publication fee · open access list price, US$
US$2,320
PSORIASIS-TARGETS AND THERAPY published 48 papers in 2025. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Who publishes in PSORIASIS-TARGETS AND THERAPY? — latest 98 articles, 2023–2026
In its latest 98 research articles (2023–2026), authors are most often from China (39.1%), Italy (14.6%) and Germany (10.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for PSORIASIS-TARGETS AND THERAPY? — indicators, not proof of misconduct
Scopus status: Not in the Scopus source list. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusNot in the Scopus source list
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journals Journal Indexed in
Psychology Research and Behavior Management Scopus Q1 WoS SSCI DOAJ Reports in Medical Imaging Not in these indexes RESEARCH AND REPORTS IN TROPICAL MEDICINE WoS ESCI DOAJ Research and Reports in Urology Scopus Q1 WoS ESCI DOAJ RESEARCH REPORTS IN CLINICAL CARDIOLOGY WoS ESCI DOAJ Risk Management and Healthcare Policy Scopus Q2 WoS SCIE/SSCI DOAJ Stem Cells and Cloning: Advances and Applications Scopus Q2 WoS ESCI DOAJ SUBSTANCE ABUSE AND REHABILITATION WoS ESCI DOAJ
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.